vimarsana.com

Page 11 - வெற்றி புற்றுநோய் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Research roundup: Recent grants and publications for Emory faculty and staff

Rollins receives $6 million grant from Gilead’s HIV initiative Emory’s Rollins School of Public Health has announced a $6 million grant from Gilead Sciences, Inc. over three years to continue to build the capacity of organizations working on the frontlines of the HIV crisis in communities across the Southern United States. Emory will serve as one of four Gilead COMPASS coordinating centers alongside the Southern AIDS Coalition, the University of Houston Graduate College of Social Work, and Wake Forest School of Divinity to provide direct support to local community organizations to help mitigate the HIV epidemic in the South.  This is part of a second wave of funding from Gilead, manufacturer of antiretroviral therapies for HIV/AIDS. Emory’s COMPASS coordinating center has directly distributed more than $4.3 million to 104 community organizations, and is directed by Neena Smith-Bankhead, director of capacity building and community engagement. More information here.

Deborah Watkins Bruner to receive Fagin Distinguished Researcher Award

 E-Mail PHILADELPHIA (March 12, 2021) - The biennial award honors the best scholarly qualities that Dr. Fagin, the School s third Dean, exemplified. It is given to a Penn Nursing faculty member, or a graduate from the School s doctoral program, who has made a distinguished contribution to nursing scholarship. Dr. Bruner will deliver the lecture Inspiration, Innovation and Impact virtually during the award presentation on April 15, 2021 from 3-4:30 PM EST. Deborah Watkins Bruner, RN, PhD, FAAN, is Senior Vice President for Research at Emory University in Atlanta, Georgia. Bruner is also Professor and Robert W. Woodruff Chair in Nursing, Professor of Radiation Oncology, and a member of the Winship Cancer Institute. She is an internationally renowned researcher and clinical trialist with a focus on patient reported outcomes, symptom management, and comparative effectiveness of radiotherapy modalities.

New At-Home Genetic Test Shows Risk Of Multiple Types Of Cancer

  A company whose goal is to identify those at risk for cancer has developed a way to screen for more than 60 cancer susceptibility genes. The work is being done at Emory Medicine’s department of human genetics. GPB’s Ellen Eldridge has more. Caption Young, Black women are disproportionally affected by breast cancer, which is associated with the BRCA genes. Credit: Photo by Godisable Jacob from Pexels A national public health initiative based out of Emory University School of Medicine’s Department of Human Genetics recently announced a new program that offers at-home testing for 63 cancer susceptibility genes associated with hereditary risks for breast, ovarian, prostate, colorectal, skin and many other cancers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.